5.13 Brevetto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.758
EU - Europa 6.686
AS - Asia 5.071
SA - Sud America 541
AF - Africa 101
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 1
Totale 20.179
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.668
IT - Italia 1.646
CN - Cina 1.458
RU - Federazione Russa 1.342
SG - Singapore 1.221
SE - Svezia 1.136
IE - Irlanda 760
KR - Corea 685
TR - Turchia 543
DE - Germania 475
BR - Brasile 414
UA - Ucraina 388
VN - Vietnam 387
GB - Regno Unito 299
HK - Hong Kong 299
FR - Francia 176
FI - Finlandia 161
IN - India 131
CH - Svizzera 114
BD - Bangladesh 57
AT - Austria 49
IQ - Iraq 47
PK - Pakistan 41
CA - Canada 38
AR - Argentina 35
MX - Messico 34
ZA - Sudafrica 32
SA - Arabia Saudita 30
ID - Indonesia 27
NL - Olanda 26
VE - Venezuela 25
PL - Polonia 23
AL - Albania 22
UZ - Uzbekistan 22
AE - Emirati Arabi Uniti 21
CO - Colombia 21
ES - Italia 21
EU - Europa 21
JP - Giappone 18
BE - Belgio 17
MY - Malesia 17
EC - Ecuador 16
TN - Tunisia 15
MA - Marocco 14
PH - Filippine 12
LT - Lituania 10
EG - Egitto 9
PE - Perù 9
CL - Cile 7
DZ - Algeria 7
ET - Etiopia 7
IL - Israele 7
AZ - Azerbaigian 6
JO - Giordania 6
PY - Paraguay 6
UY - Uruguay 5
KG - Kirghizistan 4
NP - Nepal 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
BG - Bulgaria 3
BO - Bolivia 3
CZ - Repubblica Ceca 3
JM - Giamaica 3
SN - Senegal 3
AM - Armenia 2
BY - Bielorussia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
HU - Ungheria 2
IR - Iran 2
KE - Kenya 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
LY - Libia 2
ME - Montenegro 2
OM - Oman 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
AU - Australia 1
BH - Bahrain 1
BJ - Benin 1
BW - Botswana 1
CI - Costa d'Avorio 1
CY - Cipro 1
DJ - Gibuti 1
DM - Dominica 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
IM - Isola di Man 1
IS - Islanda 1
KH - Cambogia 1
KW - Kuwait 1
MK - Macedonia 1
MM - Myanmar 1
Totale 20.166
Salva come PNG Salva come JPEG
Città #
Pisa 983
Jacksonville 864
Dublin 760
Chandler 751
Dallas 738
Ashburn 693
Seoul 683
San Jose 619
Singapore 473
Boardman 469
Izmir 404
Wilmington 365
Ann Arbor 328
Moscow 320
Beijing 305
Hong Kong 284
Hefei 253
Düsseldorf 185
Boston 180
Millbury 176
Dong Ket 150
Kent 117
San Mateo 116
Los Angeles 111
Istanbul 110
Mestre 108
Lauterbourg 106
The Dalles 99
Bern 92
Seattle 87
Woodbridge 85
Milan 82
Dearborn 79
Ho Chi Minh City 79
New York 79
Bremen 76
Lawrence 71
Ogden 66
Scuola 65
North Bergen 62
Hanoi 58
Princeton 55
Chicago 45
Santa Clara 45
Buffalo 44
Guangzhou 43
Saint Petersburg 43
Vienna 43
San Giuliano Terme 39
Munich 38
Brescia 36
São Paulo 34
Helsinki 33
Orem 33
Council Bluffs 32
Chennai 31
Shanghai 30
Rome 28
Wuhan 22
Brooklyn 21
Nanjing 21
Padova 21
Warsaw 21
Johannesburg 19
Tashkent 19
Florence 18
Kunming 18
Zurich 18
Manchester 17
Washington 17
Baghdad 16
Brussels 16
Montreal 16
Frankfurt am Main 15
Tokyo 15
Andover 14
Jiaxing 14
Lahore 14
London 14
Norwalk 14
Toronto 14
Atlanta 13
Da Nang 13
Jinan 13
Turku 13
Bientina 12
Dhaka 12
Mexico City 12
Phoenix 12
Poplar 12
Rio de Janeiro 12
Yiwu 12
Amsterdam 11
Cambridge 11
Fairfield 11
San Francisco 11
Stockholm 11
Ankara 10
Denver 10
Haiphong 10
Totale 12.998
Salva come PNG Salva come JPEG
Nome #
Liquid motion control device for Lab-on-a-Chip (LOC) system of e.g. food analysis apparatus, has control unit with acoustic resonator that reflects surface acoustic wave (SAW) when quantity of liquid is present within acoustic resonator 324
METODO PER ANIMARE SULLO SCHERMO DI UN COMPUTER UNA PENNA VIRTUALE CHE SCRIVE E DISEGNA 311
METHOD TO ANIMATE ON A COMPUTER SCREEN A VIRTUAL PEN WHICH WRITES AND DRAWS 311
METHOD TO ANIMATE ON A COMPUTER SCREEN A VIRTUAL PEN WHICH WRITES AND DRAWS 298
VECTOR FOR THE RELEASE OF AN ACTIVE AGENT WHICH IS PHOTOCLEAVABLE BY IRRADIATION IN THE VISIBLE 289
Composti particolarmente catalizzatori di poliuretani 278
METHOD TO SYNCHRONIZE AUDIO AND GRAPHICS IN A MULTIMEDIA PRESENTATION 272
Dispositivo automatizzato per la riabilitazione motoria e per la valutazione della funzionalità degli arti anteriori in modelli animali 272
COMPOSIZIONI IN GRADO DI PREVENIRE EVENTI NEURODEGENERATIVI E METODO PER SAGGIARNE L'ATTIVITA' 266
Method and device for measuring position and mass 258
Superfici funzionali con morfologia controllata sulla scala nanometrica atte a modulare l’adesione, vitalità e proliferazione di cellule 247
ANIMALI TRANSGENICI NON UMANI ANTI-NGF 242
NACYLUREA COMPOUNDS FOR PREPARING POLYURETHANES 241
Determinazione dell'organizzazione supramolecolare di molecole incapsulate tramite analisi del tempo di vita della luminescenza 240
METHOD TO SYNCHRONIZE AUDIO AND GRAPHICS IN A MULTIMEDIA PRESENTATION 236
MUTEINS OF HNGF, THERAPEUTIC USES AND PHARMACEUTICAL COMPOSITIONS 233
Laser circolari a semiconduttore con reticoli per emissione verticale 220
Bucket brigade address decoding architecture for classical and quantum random access memories 218
Metodo non invasivo per misurare il contenuto idrico assoluto di una foglia 218
Vettore per il rilascio di un agente attivo, fotoscindibile per irraggiamento nel visibile 217
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 203
Use of an anti-NGF IgG4 isotype antibody for treating and/or preventing chronic pain 196
Nanoresonator structure used as nanosensor for e.g. medical application, comprises conductive material layers and dielectric layer, and is represented by specific circuit with resonant frequency determined by geometrical dimensions 195
VECTOR FOR THE RELEASE OF AN ACTIVE AGENT WHICH IS PHOTOCLEAVABLE BY IRRADIATION IN THE VISIBLE 188
NOVEL ANALGESIC TREATMENT WITH PROLONGED EFFECT 185
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 184
Method for Ensuring privacy while querying a database by using quantum superpositions and multiple responses 182
COMPOSITIONS ABLE TO PREVENT NEURODEGENERATIVE PROCESSES AND METHODS OF ASSAYING THE SAME 181
Method for the humanization of antibodies and humanized antibodies thereby obtained 180
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 179
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT. 175
Method for the humanization of antibodies and humanized antibodies thereby obtained 173
INTRACELLULAR ANTIBODIES 173
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 172
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 170
Method for the humanization of antibodies and humanized antibodies thereby obtained. 168
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 167
ANIMALI TRANSGENICI NON UMANI ESPRIMENTI ANTICORPI ANTI-NGF. 167
Method for the potentiation of opioid analgesics effects on pain 166
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 159
Novel analgesic treatment with prolonged effect 159
Intracellular selection 159
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 159
Method for the humanization of antibodies and humanized antibodies thereby obtained. 158
METODO PER IDENTIFICARE UN INIBITORE SELETTIVO DEL PRONGF E INIBITORI SELEZIONATI CON ESSO 158
Selection of intracellular immunoglobulins 158
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 157
Method for the potentiation of opioid analgesics effects on pain 157
Non human transgenic animal as a model of neurodegenerative diseases and for the early diagnosis thereof 157
Selection of intracellular immunoglobulins 157
Method of identifying a consensus sequence for intracellular antibodies 157
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 156
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 156
Humanized anti-NGF antibodies 156
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 155
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 155
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 154
Humanized anti-NGF antibodies 154
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 153
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 152
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 152
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 152
Intracellular selection 152
Intracellular selection 152
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 152
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TRKA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 152
Method for the humanization of antibodies and humanized antibodies thereby obtained 151
null 150
Novel analgesic treatment with prolonged effect 150
Selection of intracellular immunoglobulins 149
Compositions able to prevent neurodegenerative processes and methods of assaying the same 148
NGF AND TrkA RECEPTOR BINDING INHIBITING MOLECULES AS PROLONGED ANALGESICS 148
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 148
Selection of intracellular immunoglobulins 148
METHOD FOR ISOLATING INTRACELLULAR ANTIBODIES ABLE TO NEUTRALIZE PROTEIN INTERACTIONS 148
INTRACELLULAR ANTIBODIES 148
METHOD FOR ISOLATING INTRACELLULAR ANTIBODIES ABLE TO NEUTRALIZE PROTEIN INTERACTIONS 147
SEQUENZE CONSENSO PER ANTICORPI INTRACELLULARI E LORO USO 147
TRANSGENIC MICE FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 146
Humanized anti-NGF antibodies 145
Method for the humanization of antibodies and humanized antibodies thereby obtained. 145
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 144
Non-human transgenic animals for the study of neurodegenerative syndromes 144
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 144
Method for the humanization of antibodies and humanized antibodies thereby obtained 144
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 144
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 144
Selection of intracellular immunoglobulins 143
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 143
METHOD FOR ISOLATING INTRACELLULAR ANTIBODIES ABLE TO NEUTRALIZE PROTEIN INTERACTIONS 143
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 142
Molecules that are able to inhibit the binding between NGF and the Trka receptor as analgesics with prolonged effect 142
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 141
Method for the humanization of antibodies and humanized antibodies thereby obtained. 140
Method for the humanization of antibodies and humanized antibodies thereby obtained. 140
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 140
Method for the potentiation of opioid analgesics effects on pain 139
Novel analgesic treatment with prolonged effect 139
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 139
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 139
Totale 17.705
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021627 0 0 0 0 0 0 0 0 0 268 91 268
2021/2022928 123 0 24 125 15 5 10 70 50 58 19 429
2022/20233.520 241 136 136 219 161 380 0 982 1.122 22 38 83
2023/20241.181 209 48 93 31 53 127 18 119 199 22 19 243
2024/20253.265 93 34 178 172 477 14 42 188 657 153 603 654
2025/20266.634 556 671 988 697 302 322 1.128 466 986 518 0 0
Totale 20.349